WA
JAZZ icon

Waddell & Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Waddell & Associates’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Buy
+838
New +$184K 0.01% 517

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Waddell & Associates's JAZZ Position: Q2 2026 in Review

Waddell & Associates opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 838 shares worth $202K. The stake represents 0.01% of the portfolio and ranks #517 among its holdings.

161 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Waddell & Associates held 838 shares of Jazz Pharmaceuticals worth $202K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Waddell & Associates position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.01% of Waddell & Associates's portfolio in Q2 2026, its #517 holding.
  • 161 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.